DNA interstrand cross-links (ICLs) are critical cytotoxic lesions produced by cancer chemotherapeutic agents such as the nitrogen mustards and platinum drugs; however, the exact mechanism of ICL-induced cell death is unclear. Here, we show a novel mechanism of p53-independent apoptotic cell death involving prolonged cell-cycle (G 2 ) arrest, ICL repair involving HR, transient mitosis, incomplete cytokinesis, and gross chromosomal abnormalities resulting from ICLs in mammalian cells. This characteristic 'giant' cell death, observed by using time-lapse video microscopy, was reduced in ICL repair ERCC1-and XRCC3-deficient cells. Collectively, the results illustrate the coordination of ICL-induced cellular responses, including cell-cycle arrest, DNA damage repair, and cell death.
The cellular fate after the ICL-induced G 2 arrest is, however, poorly understood. Cells can continuously arrest or die in G 2 . 20 Alternatively, cells may progress through G 2 with the induction of cell death in mitosis, 21 or the subsequent G1 or S phase. 12 The detailed mechanism and timing of ICL-induced cell death are still to be elucidated.
Cell death has an important role in the elimination of damaged cells. Necrosis and apoptosis are often observed following extensive DNA damage. While necrosis characteristically results in cell swelling and plasma membrane rupture, apoptosis produces nuclear condensation, cell shrinkage, loss of cell-cell or cell-substrate contact, 22 mitochondrial release of cytochrome-c, and activation of caspase cascades leading to DNA fragmentation. 23 Apoptotic-like G 2 20 and mitotic cell death, which is linked to abnormal chromosomal segregation and failure of mitosis, 21 are observed following mitotic-disrupting drugs. Escaping cell death at G 2 /M may result in tetraploidy 24 or polyploidy. 25 The aim of this study was to elucidate the mechanism of cell death resulting from ICL by the clinically used nitrogen mustard mechlorethamine (HN2). This is evaluated in relation to cell-cycle response and repair of ICL damage using DNA-repair-deficient Chinese hamster ovary (CHO) cell lines and human cervix carcinoma (HeLa) cells. The fate of cells following ICL damage is investigated by using time-lapse video microscopy. Collectively, these studies show the coordination of ICL-induced cell-cycle arrest, DNA damage repair, and cell death. Our data more fully define the mechanism of ICL-induced cell death following cell-cycle arrest and failure of ICL repair.
Results
DNA ICLs induce cell death associated with prolonged G 2 cell-cycle arrest. DNA ICLs are critical cytotoxic lesions, and the number of ICLs formed increases with the concentration of bifunctional ICL agents (Supplementary Figure S1 ). 2, 26 To investigate the relationship between cytotoxicity and cell-cycle response resulting from ICL formation, we performed clonogenic cell survival and cell-cycle analyses in wild-type CHO (AA8) cells after exposure to HN2 for 1 h. A dose-dependent decrease in cell survival was observed, with an LD 50 (lethal dose, 50%) of 5 mM (Figure 1a ). Moreover, a dose-dependent induction of G 2 arrest at 12 h was observed in AA8 cells following exposure to HN2 (Figure 1b ).
To examine induction and prolongation of G 2 arrest, we performed phase-dependent cell-cycle analysis in bromodeoxyuridine (BrdU) pulse-labelled cells by using flow cytometry following 10 mM (LD 80 ) HN2 treatment ( Figure 1c ).
It was observed that cells treated with HN2 during any phase of the cell cycle were subsequently arrested in G 2 and this persisted for up to 48 h. HN2 treatment of cells in G1, S, and G2 induced G2 arrest but at different time points (Figure 1c ). HN2-treated cells in G 1 progressed through S-phase and were subsequently arrested in G 2 by 24 h, which persisted up to 48 h. Cells treated in S-phase (Figure 1c , bottom) were also arrested at the subsequent G 2 phase as early as 12 h after treatment and persisted up to 48 h. Interestingly, the percentage of G 2 cells relative to G 1 cells in BrdU-negative cell fractions at 0 h (19.4%) was slightly decreased at 6 h (16.8%) as compared with a significant increase at later time points (66.59% at 12 h, 90.58% at 24 h, and 81.9% at 48 h). This may indicate that cells in G 2 at the time of HN2 treatment were not arrested in this phase and either completed the first cytokinesis or underwent cell death (Figure 1c and Supplementary Figure S2 ).
To determine any difference in sensitivity to ICLs depending on the cell-cycle phases, we performed Hoechst-33342 Cell-cycle histograms (DNA content versus cell count) of AA8 cells treated with HN2 (10 mM) were acquired by flow-cytometric analysis. Cells that had undergone apoptosis and produced a sub-G 1 population (floating cells) were excluded from this analysis. (c) Maintenance of G 2 arrest in AA8 cells treated with HN2. BrdU cellcycle analysis of AA8 cells treated with HN2 (10 mM). The dot plots represent incorporation of BrdU (y-axis) against DNA content (x-axis) of untreated control and HN2-treated cells. BrdU-positive cells were gated and their DNA profiles are shown. Floating cells were excluded from this analysis. (d) Difference in sensitivity to HN2 between cells in the G 1 and G 2 phases of the cell cycle. Hoechst-33342-stained live G 1 and G 2 cells were sorted according to DNA content by using a FACS Vantage cell sorter (BD BioSciences). After HN2 treatment, subsequent clonogenic cell survival of G 1 and G 2 cells was determined. The data are presented as mean±S.E.M. staining and live cells were sorted into G 1 and late-S/G 2 phases on the basis of their DNA profile at the time of HN2 treatment. Cells in late-S/G 2 were approximately two-fold more resistant to HN2 than cells in G 1 (Figure 1d ), which suggests that the G 1 cells died after the first S-phase because of the cytotoxicity induced as a result of attempted replication of cross-linked DNA. This may imply a failure to block cellcycle progression even with unresolved DNA synthesis. By contrast, cells in G 2 do not replicate their DNA until after division and therefore twice as many cells may contribute to the two-fold higher resistance of G 2 cells to HN2.
Cellular fate following ICL damage. To investigate the fate of cells following ICL-induced G 2 arrest, HN2-treated (10 mM) AA8 cells were observed for 72 h by time-lapse video microscopy ( Figure 2 ). The number of HN2-treated cells was decreased by 72 h, indicating both suppression of cell division and induction of cell death (Supplementary Figure S3 ). Most of the HN2-treated cells (490%) showed 'giant' cell formation. The HN2-treated cells did not undergo cell death in G 2 . Instead, they underwent pseudo-division (incomplete cytokinesis) after entry into a transient mitosis, which resulted in tetraploid (4n) G 1 cell death associated with multinucleated DNA (Figure 2a ). Remarkably, some giant cells progressed through mitosis and were capable of attempted cell division into two daughter cells. However, this cytokinesis was only temporary because both daughter cells were fused together and became a multinucleated, tetraploid G 1 cell, which consequently resulted in tetraploid G 1 cell death (Figure 2b ).
For a detailed observation of the chromosome dynamics during HN2-induced incomplete cytokinesis, we generated histone-H2B-GFP-expressing AA8 cells and continuously observed them by fluorescence video microscopy. HN2treated cells demonstrated the formation of giant cells associated with an increase in the size of the interphase nucleus, chromosomal condensation, and transient mitosis without any evidence of proper metaphase chromosome alignment at the equator of the spindle (Figure 2c ) compared with untreated control cells (Supplementary Figure S4) . Thereafter, the HN2-treated cells exited from transient mitosis without showing proper anaphase characterised by synchronous chromatid separation; instead, small multi-nuclei and multinucleated G 1 cells were formed after incomplete cytokinesis ( Figure 2c ). Therefore, after prolonged G 2 arrest, the ICL-damaged cells underwent tetraploid G 1 cell death associated with incomplete cytokinesis.
ICL induces apoptosis after prolonged G 2 arrest. We next investigated the mechanism and the timing of giant cell death. Phosphatidylserine (PS) cell membrane externalisation, mitochondrial permeablisation, and activation of caspases were examined as typical features of apoptosis. In response to a 1-h HN2 treatment (10 mM), the number of apoptotic (Annexin-V-positive and PI Low ) and dead (Annexin-V-positive and PI High ) cells were significantly increased between 24 and 72 h (Figures 3a-c). We then examined mitochondrial permeablisation by a decrease in LDS-751 intensity concomitant with a collapse in mitochondrial membrane potential. In agreement, the AA8 cells showed mitochondrial potential change (LDS-751 Low and TO-PRO-3 Low cells) and cell death associated with mitochondrial membrane potential collapse (LDS-751 Low and TO-PRO-3 High cells) between 24 and 72 h following HN2 treatment (Figures 3d-f ). Moreover, activation of caspase-3 was detected at 48 h following HN2 treatment (Figures 4a and b ). 27 Together, these results suggest that cell death was associated with the typical morphological and biochemical features of apoptosis.
To examine ICL-induced cell death and cell-cycle profiles, sub-G 1 analysis was conducted following equitoxic monofunctional (HN1) and bifunctional (HN2) nitrogen mustard treatment. HN1 can extensively alkylate cellular DNA but can only produce monoadducts and only shows cytotoxicity at very high concentrations compared with bifunctional HN2 (the LD 80 were 1000 and 10 mM for HN1 and HN2, respectively 2 ). Although both HN1 and HN2 induced significant increases in the sub-G 1 cells starting at 24 h following LD 80 treatments, the cell-cycle responses between HN1-and HN2-treated cells were distinct (Figures 4c-f ). The HN1-treated samples showed an accumulation of sub-G 1 cells in non-phasespecific DNA fragmentation without induction of significant G 2 arrest (Figure 4d ). By contrast, the HN2-treated samples showed an accumulation of sub-G 1 cells following G2 arrest with tetraploid (4n) DNA ( Figure 4e ). Taken together, these data suggest that apoptosis was induced following prolonged G 2 arrest in an ICL-induced tetraploid G 1 state. Giant cells induce p53-independent apoptosis with chromosomal abnormalities. We examined interphase nuclei and metaphase chromosomes in HN2-treated AA8 cells during transient mitosis. We observed an enlargement of interphase nuclei and increased chromosomal aberrations such as chromosome crossing-over and ring structures at 48 h after HN2 treatment as compared with untreated control cells ( Figure 5a ). Further enlargement of the interphase nuclei and chromosomal amplification were observed at 72 h. Inhibition of cytokinesis has been reported following X-irradiation, 28, 29 thus cells may override G 2 the damage checkpoint following ICL damage, which may have resulted in chromosomal abnormalities and tetraploid G 1 cell death associated with incomplete cytokinesis. This result also suggests that excess ICL-repair processing, such as by HR repair, participates in the formation of abnormal chromosomes and ICL-induced cell death. p53 has been shown to be required for apoptotic cell death induced by various DNA damage. 19 To investigate whether the tetraploid G 1 apoptosis triggered by gross chromosomal abnormalities resulting from ICL is p53-dependent, we examined the apoptotic profiles of AA8 cells transfected with dominant-negative p53 (dn-p53) 30 following HN2 treatment. Overexpression of dn-p53 did not affect the percentage of apoptotic and dead cells, as determined by Annexin-V (Figure 5b , left) and sub-G 1 (Figure 5b , right) analysis. Because overexpression of dn-p53 can inhibit p53-family members (p53, p63, p73), 31 these results suggest that the ICL-induced tetraploid G 1 cell death observed in AA8 cells is independent of p53.
To investigate whether ICL induces giant cell death in a human cancer cell, we analysed HN1-and HN2-treated HeLa cells. The HeLa cells were sensitive to HN2, with an approximate 100-fold increased sensitivity over monofunctional HN1 (Figure 5c ). Both HN1 and HN2 induced typical apoptosis in HeLa cells following exposure to equitoxic concentrations (90% growth inhibition, GI 90 ) of these agents, as determined by fluorescence video microscopy and sub-G 1 analysis (Supplementary Figure S5 and Supplementary Figure S6 ). Lower concentrations (GI 50 ) of HN2-treated, H2B-GFP-expressing HeLa cells showed the formation of giant cells with enlarged nuclei and, consequently, giant cell death (Figure 5d ). Cell-cycle histograms showed increasing sub-G 1 peaks from 24 h after HN2 (GI 50 ) treatment following tetraploid (4n) and octaploid (8n) states ( Figure 5e ).
ICL repair increases G 2 arrest and chromosomal abnormalities following HN2 treatment. We investigated whether failure of ICL repair contributes to prolongation of G 2 arrest, gross chromosomal abnormalities, and cell death. Equitoxic doses (LD 80 ) of HN2 were determined to be 10, 0.8, and 0.3 mM for XPG (UV135)-, ERCC1 (UV96)-, and XRCC3 (irs1SF)-deficient cells, respectively ( Figure 6a ). When LD 50 values were compared, XRCC3-and ERCC1deficient cells were, respectively, 63-and 16-fold more sensitive to HN2 than their isogenic parent (AA8) cells, indicating the crucial role of HR and ERCC1 in the repair of HN2-induced DNA damage as shown previously. 2, 13 By contrast, the XPG-deficient cells showed similar sensitivity to AA8 cells, suggesting that this NER protein does not have a significant role in the repair of HN2-induced ICL lesions.
To determine the mechanism of ICL-induced cell death in the repair-deficient cells, we performed membrane and organelle analyses in XPG-, ERCC1-, and XRCC3-deficient, HN2-treated cells. We observed HN2-induced apoptosis between 24 and 72 h in these cell lines, along with increased PS membrane externalisation and mitochondrial permeablisation (Supplementary Figure S7 ). We then simultaneously examined apoptosis and cell-cycle arrest in ERCC1-and XRCC3-deficient cells following exposure to equitoxic concentrations of HN2 by sub-G 1 analysis. In agreement with the membrane and organelle analyses, both ERCC1-and XRCC3-deficient cells showed an increased number of Figure 6b ); however, G 2 arrest was only transiently induced and did not persist in these cells (Supplementary Figure S8) , in contrast to the wild-type cells (Figure 4e ).
To investigate the fate of ICL-repair-deficient cells, we generated H2B-GFP-expressing irs1SF cells and observed them for 72 h by fluorescence video microscopy following equitoxic HN2 treatment. XRCC3-deficient cells did not show giant cell death, but cell death after cell division, followed by relatively normal chromosomal segregation compared with AA8 cells in response to equitoxic HN2 treatment (Figure 6c ). Incomplete cytokinesis, which was a critical step in the formation of ICL-induced, tetraploid, multinucleated giant cells in wild-type cells (Figure 2) , was attenuated in XRCC3deficient cells. The percentage of incomplete cytokinesis relative to the number of normal cell divisions was significantly decreased in XRCC3-deficient cells as compared with the wild-type cells, as determined by a cell-tracking system Supplementary Table S1 and Supplementary Figure S9) .
Although both wild-type and XRCC3-deficient cells underwent apoptosis at similar time points (Figure 3 and Supplementary Figure S7 ), XRCC3-deficient cells showed less incomplete cytokinesis, with relatively normal cell division. We therefore investigated the chromosomal status in HN2treated, XRCC3-deficient cells. Giant interphase nuclei were not observed in XRCC3-deficient cells at 48 and 72 h following HN2 treatment (Figure 6d ). Moreover, chromosomal abnormalities were significantly decreased in XRCC3deficient cells as compared with wild-type cells (Figures 5a  and 6d ). Therefore, although both cell types undergo the same amount of cell death through apoptosis and at similar time points, less giant nuclei, chromosomal abnormalities, and amplifications were observed in XRCC3-deficient cells as compared with wild-type cells.
Discussion
DNA ICL agents are widely used in cancer chemotherapy; however, an emergence of acquired drug resistance, due at least partly to ICL repair, is a major clinical problem. 6, 7 In this study, we have investigated cell death resulting from ICL in mammalian cells, and a connection between cell death and ICL repair associated with prolonged G 2 arrest and incomplete cytokinesis has been indicated. Cellular fate following ICL damage was revealed by using time-lapse video microscopy, and the mechanism of ICL-induced cell death was confirmed as p53-independent apoptosis. The timing of cell death suggests that it is induced after an attempt to repair the ICL damage. Moreover, the trigger of cell death was initiated after a failure of cytokinesis, associated with chromosome abnormalities resulting from incomplete or inappropriate ICL repair. By contrast, an HR repair-deficient cell line showed diminished G 2 arrest, reduced giant cell formation, and a lower frequency of incomplete cytokinesis. Collectively, our results illustrate the coordination of ICL-induced cellular responses, including cell-cycle arrest, DNA damage repair, and cell death.
An investigation of the relationship between repair of DNA ICL damage, cell-cycle response, and cell death enabled the identification of a link between HR repair and ICL-induced G 2 arrest in mammalian cells. ICLs are most critical in the S-phase of proliferating cells 32 and are processed through an unhooking of ICLs and subsequent HR in the late S-to-G 2 phases. 2, 17 In agreement, our results demonstrated the hypersensitivity of ERCC1-and XRCC3-deficient cells to HN2 as determined by a colony formation assay. Moreover, the clonogenic cell-cycle analyses demonstrated ICL dosedependent cytotoxicity accompanied by induction of G 2 arrest, suggesting a connection between G 2 arrest and induction of cell death. Further investigation revealed that the persistence of ICLs, rather than the initial amount formed, activated and maintained G 2 arrest for more than 48 h in wild-type cells (Figure 1b ). 33 Importantly, XRCC3-deficient cells were severely impaired in the maintenance of G 2 arrest when compared with the wild-type cells, suggesting that HR repair contributes to the maintenance of G 2 arrest induced by DNA-cross-linking drugs.
The fate of the ICL damage following a prolonged G 2 arrest is characterised as a multinucleated, tetraploid G1 cell death associated with incomplete cytokinesis. Activation of G 2 arrest occurs as part of the repair process of ICL damage in surviving cells, 19 and also occurs as part of the process that leads to cell death. Cell death following damage-induced G 2 arrest has been reported to occur in the G 2 , 20 M, 21 or the subsequent G 1 /S phases. 12 In the current study, ICL-damaged cells showed transient mitosis and a novel giant cell death in the tetraploid G 1 phase following the prolonged G 2 arrest. This observation highlights the importance of real-time observation using time-lapse video microscopy rather than just a single time point analysis, which can often result in the misinterpretation of cell-cycle transition events. Interestingly, this 'giant' cell death was not observed in XRCC3-defective cells, suggesting that ICL repair, especially by HR, participates not only in the maintenance of G 2 arrest, but also in ICL-induced 'giant' cell death.
A comprehensive investigation into the mechanism of ICL-induced cell death was conducted. Cell death can occur as a result of multiple processes, including apoptosis, necrosis, mitotic catastrophe, and apoptotic-like cell death, 20, 21 and can be determined by morphological and biochemical changes. Previous studies in mouse embryonic fibroblasts have indicated that alkylation DNA damage (both monofunctional and bifunctional) stimulates a regulated form of necrotic cell death independent of p53. 34 The ICL-induced tetraploid G 1 cell death observed in the current study is associated with several hallmarks of apoptotic cell death determined by four independent criteria: membrane PS externalisation, mitochondrial permeability, activation of caspases, and elevated levels of a sub-G 1 phase fraction. HN2-induced ICLs form rapidly in cells, reaching a peak by 1 h. 2 The timing of cell death after drug treatment was 24 h onwards and occurs after G 2 arrest, suggesting that cell death is initiated after an attempt at ICL damage repair. Whereas wild-type cells showed an induction of apoptosis concomitant with prolonged G 2 arrest in tetraploid (4n) cells, XRCC3deficient cells showed an induction of apoptosis after an impaired G 2 arrest in diploid (2n) cells. It is noteworthy that this type of cell death following prolonged G 2 arrest was only induced by the bifunctional alkylating agent HN2 and not by the monofunctional agent HN1 at equitoxic drug concentrations, suggesting that DNA ICLs and their processing are critical for this novel apoptotic cell death.
Wild-type cells following cross-linking drug treatment possess 'giant' nuclei with gross chromosomal abnormalities. By contrast, XRCC3-deficient cells at equitoxic doses showed diminished formation of 'giant' nuclei, with fewer chromosomal abnormalities. It is therefore likely that the abnormal chromosomes that triggered 'giant' cell death resulted from aberrant repair of ICL damage (e.g. over-processing of ICL damage repair and/or an excess of recombination events). In CHO cells, the ICL-induced tetraploid G 1 apoptosis was shown to be independent of p53-family proteins. It is notable that histone-H2B-GFP-expressing HeLa cells also demonstrated tetra/octaploid apoptosis following a prolonged cell-cycle arrest, indicating the occurrence of 'giant' cell death after an attempt to repair the ICL damage in human cancer cells. In fact, the multinucleated 'giant' cell formation and polyploid cell death could be a general hallmark of cancer, 35 as well as a cellular response to various genotoxic stimuli such as UVA exposure, 36 ionising radiation, 37 and chemotherapy, 38 and often associated with mutant p53. 39 Overall, our data suggest a mechanism of ICL-induced cell death in mammalian cells (Figure 7) .
In conclusion, the results provided here describe for the first time the occurrence of a novel mechanism of cell death following an attempt to repair ICL damage. Further investigation regarding the mechanism underlying cell death with respect to (1) ICL-induced damage-repair pathways in the regulation of the cell cycle; (2) induction of cell death following repair of ICL-induced damage; and (3) chromosomal dynamics during incomplete cytokinesis will further our understanding of the ICL-induced apoptotic cell death of cancer cells following chemotherapy. This may lead to strategies to eliminate cells that are tolerant or acquire resistance to conventional chemotherapy, and may enhance the therapeutic index in combination with newly developed antitumor agents and ultimately lead to new therapeutic strategies for the treatment of cancer.
Materials and Methods
Cell lines and culture conditions. Cells were obtained from the departmental cell bank, unless otherwise stated. Wild-type, repair-proficient (AA8), XPG-deficient (UV135), ERCC1-deficient (UV96), XRCC3-deficient (irs1SF) CHO cell lines were obtained from the departmental cell bank (Cancer Research UK Drug-DNA Interactions Research Group, London, UK). HeLa, the human cervix cancer cell line, was purchased from Cancer Research UK cell culture department (London, UK). The histone-H2B-GFP HeLa cell line was obtained from G Wahl (Salk Institute, La Jolla, CA, USA). Histone-H2B-GFP AA8, histone-H2B-GFP irs1SF and dn-p53 AA8 were generated for this study. The CHO cell lines were grown in Ham F12 nutrient medium (Sigma, Poole, UK). HeLa cells were grown in DMEM high-glucose medium (Autogen Bioclear, Calne, UK). These media were supplemented with 10% foetal bovine serum (FBS), 2 mM glutamine, and penicillin/ streptomycin at 37 1C in a humidified atmosphere containing 5% CO 2 . In addition, DMEM medium for culturing the H2B-GFP HeLa cells was supplemented with blasticidin (Invitrogen-Autogen Bioclear, Calne, UK).
Colony-based survival assay. Three hundred cells were plated onto petri dishes (100 mm) 24 h prior to HN2 treatment. Drug dilutions prepared fresh prior to the treatment and cells were treated in serum-free medium for 1 h then replaced in full medium. After 10-14 days, colonies were stained with 1% methylene blue and dried overnight. Colonies containing more than approximately 50 cells were counted.
Cytotoxicity assay. Cell proliferation was assessed by using the sulphorhodamine-B (SRB) assay as described previously. 2 Cell-cycle analysis. Cells were harvested by 5 ml of trypsin EDTA (Autogen Bioclear) after HN2 drug treatment and washed in PBS (Sigma), then fixed in icecold 70% ethanol with gentle vortexing. After a minimum of 30 min at 4 1C, the cells were washed twice in PBS and resuspended in 100 ml of 100 mg/ml ribonuclease (Sigma) and 400 ml propidium iodide (PI) (50 mg/ml) (Sigma). After incubation for 30 min, samples were analysed by using a FACSCalibur (BD BioSciences, San Jose, CA, USA), with PI fluorescence being measured above 670 nm. Cell doublets and apoptotic cells were excluded from analysis.
BrdU cell-cycle analysis. Prior to drug treatment, cells were treated with 10 mM BrdU (Sigma) for 30 min in serum-containing medium. The cells were washed twice with free medium followed by drug treatment for 1 h in serum-free medium. The cells were grown in non-drug-containing medium until an appropriate time course. After harvesting, the cells were fixed in ice-cold 70% ethanol and kept at 4 1C for at least 30 min before further processing. After washing, the cells were treated with 1.5 ml of 2 M hydrochloric acid and incubated 30 min at room temperature. A 0.5-ml volume of PBS was added and acid was spun off at 2000 r.p.m. followed by washing in 0.5 ml of PBS and in 0.5 ml of PBS-T (PBS, 0.1% BSA, Figure 7 Mechanism of cell death resulting from DNA ICLs in mammalian cells. ICL-damaged cells undergo cell death through apoptosis as a result of persistence of ICLs in G 1 , collapse of the stalled replication fork in S, inefficient or excess ICL repair in G 2 , mitotic catastrophe or incomplete cytokinesis in M, and multi-nucleation in the tetraploid G 1 phase. By contrast, ICL-damaged cells may survive after ICL removal in G 1 , translesion synthesis (TLS) in S, efficient ICL repair involving HR in G 2 , mitotic slippage in M, polyploidy in the tetraploid G 1 phase, and after endoreduplication. The pathway indicates by arrows is the one elucidated in this study, and the pathways indicated by dotted arrows are the ones proposed in previous studies 0.2% Tween-20, pH 7.4). A 2-ml volume of anti-BrdU antibody (BD BioSciences, Oxford, UK) was added directly to the cell pellet and incubated for 15 min at room temperature and samples were washed twice in PBS-T. Then the samples were stained with 50 ml of FITC-conjugated rabbit anti-mouse secondary antibody (Dako, Ely, UK) at a 1 in 100 dilution for 15 min at room temperature and washed in PBS. A 50-ml volume of RNase (100 mg/ml) (Sigma) and 300-400 ml of PI (50 mg/ml) were added just before analysis. Samples were analysed on a FACSCalibur (BD BioSciences). Cell doublets and debris were excluded and FITC fluorescence was measured between 515 and 545 nm, and PI fluorescence above 670 nm.
Cell sorting and survival assay. Cell sorting was used to select cells for the clonogenic survival assay. Cells were harvested by 5 ml of trypsin EDTA while in exponential growth. To stain cellular DNA, 10 mg/ml Hoechst-33342 (bisbenzamide; Sigma) was added and incubated at 37 1C for 1 h together with different concentrations of HN2. After the treatment, the cells were sorted depending on the cell-cycle population (G 1 and G 2 ) into culture medium based on cell integrity (forward versus side scatter) and DNA profile (Hoechst-33342 staining) by using a FACS Vantage (BD BioSciences) cell sorter. For clonogenic assays, 300-5000 cells were sorted per T25 flask depending on the expected surviving fraction after HN2 treatment to keep the number of colonies per flask at approximately 200. Three replicates were used at each dose in each experiment so at least 900 cells were assessed at each dose point. After 7-10 days of incubation at 37 1C, the flasks were stained with crystal violet (1%) and colonies of greater than 50 cells were counted manually.
Phase-contrast, time-lapse video microscopy. Cells were plated on 35 mm petri dishes 24 h prior to drug treatment. The drug-containing dishes were washed and replaced with full medium and placed onto the video camera chamber in a humidified atmosphere supplied with 5% CO 2 at 37 1C. Images were captured every 5-10 min using Â 10 to Â 20 objective lenses of an Olympus inverted microscope. Phase-contrast images were acquired by using the Kinetic Imaging software connected to a Sony CCD-IRS camera, which also controlled the shutters and the filter wheels to limit light exposure.
Fluorescence video microscopy. For monitoring living cell cultures, 5 Â 10 4 cells were plated onto 35 mm glass-bottom culture dishes (MatTek Corporation, Ashland, MA, USA) 24 h prior to any drug treatment. Histone-H2B-GFP-expressing AA8 and irs1SF cells were treated with HN2 for 1 h in a phenol red-free and serum-free HAM F12 medium (Cancer Research UK cell culture department). After the treatment, the drug-containing media were discarded and cells were washed with a phenol red-free, serum-free HAM F12 medium, and then the cells were incubated in a phenol red-free HAM F12 medium supplemented with 10% FBS and 2 mM glutamine. For image acquisition, the culture dishes were kept in a special chamber, which was kept at 37 1C in a humidified atmosphere containing 5% CO 2 . Phase-contrast images of cells and/or epifluorescence images of cell nuclei were acquired on an Axiovert TV 135 microscope (Carl Zeiss, Maple Grove, MN, USA) equipped with a Â 63 NA 1.4 objective lens and an Orca ER CCD camera (Hamamatsu, Photonics K.K., Hamamatsu, Japan) by using Acquisition Manager (Kinetic Imaging, Liverpool, UK).
Cell membrane analysis (Annexin-V versus PI). Cells were treated with drug for 1 h in a serum-free medium. After the drug treatment, the cells were washed twice with serum-free medium. Thereafter, the cells were grown in non-drugcontaining medium for the appropriate time period. After harvesting, both floating cells and adherent cells were collected and resuspended in 0.5 ml of Annexin binding buffer (10 mM HEPES/NaOH (pH 7.4), 140 mM NaCl, 2.5 mM CaCl 2 ) (Pharmingen, San Diego, CA, USA) and 3 ml of Annexin-V-FITC were added. Samples were incubated in the dark at room temperature for 20 min and 50 ml of PI (50 mg/ml) were added just before analysis. The samples were analysed by using a FACSCalibur (BD BioSciences), with FITC fluorescence being measured between 515 and 545 nm, and PI fluorescence being measured above 670 nm.
Mitochondrial permeabilisation assay. During apoptosis there is often a collapse of mitochondrial membrane potential. Laser Dye Styryl-751 (LDS-751) stains activate mitochondria and can be detected by flow cytometry. 40 Cells were treated with drug for 1 h in serum-free medium. After the drug treatment, the cells were washed twice with serum-free medium. Thereafter, the cells were grown in non-drug-containing medium for the appropriate time course. After harvesting, both floating and adherent cells were collected and resuspended in 0.5 ml of PBS and LDS-751 (Exciton, Dayton, OH, USA) to a final concentration of 100 nM and incubated at room temperature for 20 min, and before analysis 10 ml of TO-PRO-3 iodide (1 nM; Molecular Probes, Eugene, OR, USA) were added. Samples were analysed on a FACSCalibur (BD BioSciences), with LDS-751 being excited by a 488-nm laser and the emitted fluorescence measured between 560 and 600 nm. TO-PRO-3 was excited by a 633-nm laser and the emitted fluorescence was collected with a 660/16-nm band-pass filter.
Sub-G 1 analysis. Cells were treated with drug for 1 h in serum-free medium. After the drug treatment, the cells were washed twice with serum-free medium. Thereafter, the cells were grown in non-drug-containing medium for the appropriate time course. After harvesting, both floating and adhered cells were collected and fixed in ice-cold 70% ethanol with gentle vortexing and kept for a minimum of 30 min at 4 1C. Samples were washed twice in phosphate-citrate buffer (0.2 M Na 2 HPO 4 , 0.1 M citric acid, pH 7.8) and resuspended in 100 ml of RNase (100 mg/ml) and 400 ml of PI (50 mg/ml). After incubation for 30 min, the samples were analysed by using a FACSCalibur (BD BioSciences), with PI fluorescence being measured above 670 nm. Cell doublets and aggregates were excluded from analysis.
Activation of caspase-3 determined by western blotting. Cell samples were prepared as described previously. 27 Briefly, Cells were washed with PBS and lysed in ice-cold NP-40 blase buffer (2% NP-40, 2 mM NaO 4 Va, 50 mM NaF, 20 mg/ml Apro, 20 mg/ml leupeptine, 20 mg/ml bensamidine). Total cellular proteins (10-20 mg) were boiled in 4 Â sample buffer (250 mM Tris-HCl (pH 6.8), 8% SDS, 40% glycerol, 20% b-mercaptoethanol, 1 mg/10 ml bromophenol blue) and separated on 12-15% SDS polyacrylamide gels and blotted onto nitrocellulose overnight. After the transfer, the membranes were washed in PBS and PBS-T, and incubated with a cleaved caspase-3 rabbit monoclonal antibody (Cell Signaling Technology, Beverly, MA, USA), followed by subsequent incubation with a horseradish peroxidase-conjugated anti-rabbit secondary antibody (Amersham, Little Chalfont, UK). Immunoreactive bands were visualised by enhanced chemiluminescence (Amersham).
Metaphase chromosome and interphase nucleus preparation.
After 1 h of HN2 treatment, cells were incubated in medium containing 0.05 mg/ml colcemid (Gibco, Grand Island, NY, USA) at 37 1C for 1 h. The cells were treated with a hypotonic solution of 0.075 M KCl for 15 min at room temperature. The cells were then fixed three times with methanol/acetic acid (3 : 1) and metaphase preparations were made. The slides were mounted in a DAPI/Antifade mounting medium (Abbott Laboratories, Kent, UK). Spectral images were captured by using a CCD camera attached to AX10 plan microscope (Zeiss, Birmingham, UK).
Production of histone-H2B-GFP and dn-p53-expressing cells. H2B-GFP expression pCLNR-H2BG 41 and a dn-p53, pBabepuro-p53 175 plasmids were transfected together with a packaging pHIT60 carrying MLV gag-pol, and an envelope glycoprotein expression plasmid, pMD-G, encodes the vesicular stomatitis virus G-protein (VSV-G) under the control of the hCMV promoter. Transfection of 293T cells was conducted by using Lipofectamine (Invitrogen, Paisley, UK) as described in the manufacturer's instructions. CHO cells were plated at 1 Â 10 5 cells per well in 24-well plates 24 h before infection. On the day of infection, the filtered supernatant was serially diluted in OptiMEM and added to the wells in the presence of 1 Â 10 5 mg/ml polybrene (hexadimethrine bromide, Sigma). The cells were incubated overnight at 37 1C. The virus was then washed off the cells and replaced with HAM F12 containing 10% FCS. Cells expressing H2B-GFP were sorted by using a FACS Vantage (BD BioSciences). The cells were then cultured and maintained in HAM F12 medium. The dn-p53-expressing cells were selected by using a HAM F12 medium containing 10 mg/ml puromycin for 2 weeks.
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